NEW YORK (GenomeWeb News) – The China National Genebank today announced a deal under which BioStorage Technologies will provide biorepository expertise, technology, and processes to support the development of "one of the world's largest genomic biobanks."
The CNGB was established by BGI-Shenzhen and said it is the first national genebank in China "to integrate an omics database and a large-scale biorepository consisting of 30 million biological samples, including human, animal, plant, and microorganism samples." Samples stored in CNGB will be used for research and "potential industrialization, such as translational medicine, breeding, and new energy exploitation."
BioStorage is supporting the growth of CNGB through a partnership with BGI-Shenzhen. Its sample management technology system is called Intelligent Specimen Inventory Storage System, or ISISS, and the combination of the system with "BGI's scientific and data capabilities provide the CGNB with the global capabilities required to be a vital asset to the research industry," Greg Swanberg, CEO of Indianapolis-based BioStorage, said in a statement.
Financial and other terms of the deal were not disclosed.